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Abstract
BACKGROUND—There is evidence in experimental model systems that exposure to polycyclic 
aromatic hydrocarbons (PAHs) results in congenital heart defects (CHDs); however, to our 
knowledge, this relationship has not been examined in humans. Therefore, we conducted a case-
control study assessing the association between estimated maternal occupational exposure to 
PAHs and CHDs in offspring.
METHODS—Data on CHD cases and control infants were obtained from the National Birth 
Defects Prevention Study for the period of 1997 to 2002. Exposure to PAHs was assigned by 
industrial hygienist consensus, based on self-reported maternal occupational histories from 1 
month before conception through the third month of pregnancy. Logistic regression was used to 
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evaluate the association between maternal occupational PAH exposure and specific CHD 
phenotypic subtypes among offspring.
RESULTS—The prevalence of occupational PAH exposure was 4.0% in CHD case mothers 
(76/1907) and 3.6% in control mothers (104/2853). After adjusting for maternal age, race or 
ethnicity, education, smoking, folic acid supplementation, and study center, exposure was not 
associated with conotruncal defects (adjusted odds ratio [AOR], 0.98; 95% confidence interval 
[CI], 0.58–1.67), septal defects (AOR, 1.28; 95% CI, 0.86–1.90), or with any isolated CHD 
subtype.
CONCLUSIONS—Our findings do not support an association between potential maternal 
occupational exposure to PAHs and various CHDs in a large, population-based study. For CHD 
phenotypic subtypes in which modest nonsignificant associations were observed, future 
investigations could be improved by studying populations with a higher prevalence of PAH 
exposure and by incorporating information on maternal and fetal genotypes related to PAH 
metabolism.
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INTRODUCTION
Congenital heart defects (CHDs) are the most common group of structural defects, occurring 
in approximately 1 of every 100 births (Botto et al., 2007). In addition to being the most 
prevalent group of birth defects, CHDs are the leading cause of birth defect–related 
mortality (Jenkins et al., 2007). Although some CHDs occur in association with known 
genetic disorders (e.g., 22q11 deletion syndrome) and teratogenic exposures (e.g., maternal 
pregestational diabetes), the majority (approximately 80%) are of unknown etiology 
(Harper, 2004). Suspected risk factors for CHDs include maternal obesity (indexed by body 
mass index [BMI]) and maternal folate status (Jenkins et al., 2007). In addition, occupational 
exposures have been suggested as potential risk factors for CHDs (Herdt-Losavio et al., 
2010).
There is evidence in experimental model systems that prenatal exposure to polycyclic 
aromatic hydrocarbons (PAHs) is associated with CHDs (Farwell et al., 2006; Incardona et 
al., 2004). Additionally, studies in humans suggest maternal occupational and environmental 
exposure to PAHs is associated with structural birth defects including neural tube defects 
(Naufal et al., 2010; Ren et al., 2011; Langlois et al., 2012) and gastroschisis (Lupo et al., 
2012). Despite this evidence, to our knowledge there have been no studies evaluating the 
potential association between maternal occupational exposure to PAHs and CHDs among 
offspring.
The identification of risk factors for CHDs is complicated by the vast range of cardiac defect 
phenotypes (e.g., tetralogy of Fallot, hypoplastic left heart syndrome), which may differ in 
their underlying etiology. It is therefore important to study specific phenotypic subtypes of 
CHDs and evaluate associations among those cases that have been properly classified (Botto 
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et al., 2007). To this end, we used data from the National Birth Defects Prevention Study 
(NBDPS), the largest population-based case-control study of birth defects in the United 
States; it offers a unique opportunity to explore the association between maternal 
occupational exposure to PAHs and specific phenotypic subtypes of CHDs among offspring 
because of its detailed review and refined classification of CHD cases and the industrial 
hygienist–estimated maternal occupational exposure information for PAHs among study 
participants who delivered from 1997 through 2002.
MATERIALS AND METHODS
Study Participants
The study population included CHD case and unaffected control infants from the NBDPS, 
with estimated dates of delivery from October 1, 1997, through December 31, 2002. NBDPS 
cases were identified from eight birth defects surveillance systems throughout the United 
States: Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, and 
Texas (Yoon et al., 2001). Case infants were live born, stillborn, or electively terminated. 
Control infants (live born infants without major birth defects) were selected randomly from 
birth certificates or birth hospital records from the same geographic populations that gave 
rise to the cases. Mothers of cases and controls completed a 1-hour computer-assisted 
telephone interview (CATI) in either English or Spanish from 6 weeks to 2 years after the 
estimated date of delivery. Interviewers obtained information on maternal demographic 
characteristics, exposures (e.g., nutritional and occupational) and medication use both before 
and during pregnancy. The Centers for Disease Control and Prevention (CDC) Institutional 
Review Board (IRB), along with the IRBs for each participating state, have approved the 
NBDPS. In addition, this analysis was approved by the IRB of The University of Texas 
Health Science Center at Houston.
Classification of CHDs
The systematic review of all NBDPS case records by clinical geneticists resulted in the 
exclusion of those with recognized or strongly suspected single-gene conditions or 
chromosome abnormalities. All CHD cases were confirmed by echocardiography, cardiac 
catheterization, surgery, or autopsy (Rasmussen et al., 2003; Botto et al., 2007), and their 
diagnostic information was reviewed by a team of clinicians with expertise in pediatric 
cardiology and clinical genetics for classification on two axes. The first axis of classification 
focused on the heart itself. Simple cardiac defects were defined as anatomically discrete or a 
well-recognized single entity (e.g., hypoplastic left heart syndrome, tetralogy of Fallot). 
Associations were defined as common combinations of (typically two) cardiac defects (e.g., 
ventricular septal defect, pulmonary valve stenosis). Cases that included three or more 
distinct CHDs were considered complex (Botto et al., 2007). The second axis of 
classification considered whether the infant had defects outside the heart. Infants with no 
major extracardiac defects were classified as isolated CHD cases, whereas those with 
extracardiac defects were classified as multiple CHD cases (Rasmussen et al., 2003; Botto et 
al., 2007). Clinical reviewers also determined the specific CHD phenotypic subtypes of 
every case according to rigorous guidelines (Botto et al., 2007).
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Inclusion and Exclusion Criteria
To assess associations in relatively homogeneous case groups, we included only case infants 
with simple and isolated CHDs based on the NBDPS classification strategy described above 
(Botto et al., 2007). Because maternal pregestational diabetes, multiple gestations, and first-
degree family history of CHDs are strong and well-established risk factors for CHDs 
(Jenkins et al., 2007), we excluded all cases and controls with these characteristics. CHDs 
were analyzed by specific subtype when at least 50 cases were available for analysis.
PAH Exposure Assessment
The NBDPS CATI includes occupation-related questions for jobs held for at least 1 month 
during the period from the 3 months before conception through the end of pregnancy. 
Information collected includes job title, name of company or organization, service provided 
or product made by the company, main activities or duties, and machines used. Mothers 
reported month and year for start and stop date of each job, as well as days per week and 
hours per day worked. Each job was coded for occupation and industry using the Standard 
Occupational Classification System (SOC; United States Department of Labor Bureau of 
Labor Statistics, 2000) and the North American Industry Classification System (United 
States Department of Labor Bureau of Labor Statistics, 1997).
Expert industrial hygienists reviewed all jobs of mothers who reported any employment to 
estimate potential exposure to PAHs. This expert review strategy was based on an approach 
previously developed and used in the Baltimore-Washington Infant Study (Jackson et al., 
2004) and described previously (Langlois et al., 2012). Specifically, as part of the NBDPS 
occupational exposure assessment, industrial hygienists involved in the project participated 
in a training session before reviewing the job histories. During training, the industrial 
hygienists were given definitions of the exposure variables (e.g., exposure to any PAH in 
each job) and a sample set of 100 jobs. Each industrial hygienist independently rated the 100 
jobs, then all industrial hygienists worked together to examine the rationale and assumptions 
behind their rating decisions, including discussing mechanisms of exposure and modifying 
factors. This process was intended to help the industrial hygienists calibrate their ratings. 
After training was complete, two industrial hygienists, working independently and blinded 
to case-control status, reviewed occupational data reported during the CATI (both job title 
and work-related activities) to determine a dichotomous (yes or no) rating of potential 
occupational exposure to PAHs for each job. Discrepancies between the two industrial 
hygienists were resolved by a consensus conference that involved the original two industrial 
hygienists plus a third (Rocheleau et al., 2011). During the consensus conference, industrial 
hygienists discussed each discrepant rating until all three agreed. If they could not come to 
agreement through discussion, they reviewed the literature to inform further discussion until 
agreement was reached (Rocheleau et al., 2011).
For this analysis, we focused on potential exposures during the critical time window for the 
development of CHDs (i.e., the month before conception through the third month of 
pregnancy; Selevan et al., 2000). Therefore, a woman was classified as exposed if she had 
one or more jobs that were rated as exposed during this critical window, and she was 
classified as unexposed if all of her jobs were rated as unexposed during this same window.
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Data for maternal characteristics that are generally accepted or suspected to be associated 
with CHD risk were obtained from the CATI and included: infant sex (male or female), 
maternal age at delivery (<20, 20–34, ≥35 years); maternal race or ethnicity (non-Hispanic 
White, non-Hispanic Black, Hispanic, or other); maternal education (<12, 12, 13–15, ≥16 
years); parity (0 or ≥1 previous births); gestational diabetes (yes or no); maternal use of 
supplements containing folic acid in the month before conception through the third month of 
pregnancy (yes or no); maternal alcohol use in the month before conception through the 
third month of pregnancy (yes or no); maternal smoking in the month before conception 
through the third month of pregnancy (nonsmoker, light [<15 cigarettes per day], moderate 
[15–24 cigarettes per day] or heavy [≥25 cigarettes per day]); secondhand smoke at home in 
the month before conception through the third month of pregnancy (yes or no); secondhand 
smoke at work in the month before conception through the third month of pregnancy (yes or 
no); and maternal pre-pregnancy BMI. Maternal pre-pregnancy BMI (kg/m2) was 
categorized according to the National Heart, Lung and Blood Institute cutoff points as 
follows: underweight (<18.5 kg/m2), average weight (18.5–24.9 kg/m2), overweight (25.0–
29.9 kg/m2) and obese (≥30.0 kg/m2). To account for potential dietary sources of PAHs 
(Boers et al., 2005), data on meat consumption (none or less than once a month, one to three 
times a month, four times a month, or more than four times a month) during the year 
preceding the pregnancy of interest was obtained from a modified Willett Food Frequency 
Questionnaire (58 food items) administered during the NBDPS CATI (Willett et al., 1987). 
For meat consumption, women were asked whether they ate beef, pork, lamb, or cabrito as a 
main dish and how often they ate these items on average during the year before they became 
pregnant.
Statistical Analysis
Frequency distributions of maternal demographic and behavioral factors were tabulated for 
case and control infants. Chi-square tests were used to identify factors that were 
significantly different (p < 0.05) between case and control infants. Frequency distributions 
of the SOC major job groups (n = 23) were tabulated for mothers of cases and controls, 
stratified by occupational PAH exposure status. In addition, we used the Student’s t test to 
assess differences in mean time to interview for case and control mothers, as well as 
exposed and unexposed mothers, because the time lapse between estimated date of delivery 
and interview ranged from 6 weeks to 2 years. This was done to evaluate the potential of 
recall bias owing to differences in time to interview.
Unconditional logistic regression was used to calculate crude and adjusted odds ratios 
(AORs) and 95% confidence intervals (CIs) to estimate the association between maternal 
occupational exposure to PAHs and the odds of CHDs (as a group and by phenotypic 
subtype) in offspring. Based on previous studies, we included maternal age, race or 
ethnicity, education, smoking, folic acid supplementation, and study center in all models 
(Correa et al., 2008; Gilboa et al., 2010; Lupo et al., 2012). In addition, we incorporated 
variables as confounders in the final models if inclusion resulted in a 10% or greater change 
in the estimate of effect between maternal occupational exposure to PAHs and each of the 
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CHD subtypes assessed. All analyses were conducted using Intercooled Stata, version 10.1 
(StataCorp LP, College Station, TX).
RESULTS
Participation in the NBDPS was 71% among mothers of cases and 69% among control 
mothers. Of the 4693 CHD case mothers and 4116 control mothers included in the NBDPS 
for the period 1997 to 2002, 72% (n = 3339 CHD case mothers; n = 2993 control mothers) 
were employed for at least 1 month during the critical window of exposure (the remaining 
28% reported no job during the critical window and were not included in this analysis as to 
limit our inferences to women who were specifically employed during the critical period of 
development). CHD cases with defects designated as “associations” (n = 589) or complex (n 
= 224) were not included. In addition, CHD cases with extracardiac defects (n = 561) were 
not included. Finally, exclusions for CHD case and control infants were based on maternal 
pregestational diabetes (n = 104 CHD cases; n = 15 controls), multiple gestations (n = 237 
CHD cases; n = 95 controls), and first-degree family history of CHDs (n = 121 CHD cases; 
n = 31 controls). After exclusions, there were 1907 CHD case infants and 2853 control 
infants eligible.
Selected maternal characteristics are summarized by case-control status in Table 1. The 
distribution among the smoking categories and BMI categories were different among CHD 
case and control mothers. In addition, CHD case mothers were more likely to have 
gestational diabetes compared to control mothers. There was no significant difference in the 
average time to interview between case and control mothers (11.3 vs. 10.3 months; p = 0.32) 
or between PAH-exposed and unexposed mothers (11.3 vs. 11.4 months; p = 0.67).
Table 2 displays the number of jobs linked to the 23 SOC major job groups for mothers of 
cases and controls stratified by exposure status. Jobs in the SOC job group “Food 
Preparation and Serving Related” were the most frequent jobs among exposed case mothers 
(n = 32 of 74 individual jobs held by exposed case mothers during the critical window), 
followed by “Sales and Related Occupations” (n = 25). Similarly, the most common jobs 
among exposed control mothers were in “Food Preparation and Serving Related 
Occupations” (n = 47 of 101 individual jobs), followed by “Sales and Related Occupations” 
(n = 28). Some jobs could not be linked to the SOC major job groups and are not represented 
in Table 2.
Overall, the prevalence of occupational PAH exposure was 4.0% in CHD case mothers 
(76/1907) and 3.6% in control mothers (104/2853). In adjusted analyses (Table 3), there 
were nonsignificant positive associations between estimated maternal occupational PAH 
exposure and various CHD phenotypic subtypes ranging from an AOR of 1.19 (95% CI, 
0.68–2.10) for perimembranous ventricular septal defects to an AOR of 1.84 (95% CI, 0.72–
4.68) for muscular ventricular septal defects. Also, nonsignificant negative associations were 
seen for right ventricular outflow tract defects (AOR, 0.54; 95% CI,: 0.23–1.24) and 
pulmonary valve stenosis (AOR, 0.51; 95% CI, 0.19–1.42).
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Our analyses did not indicate that estimated maternal occupational exposures to PAHs were 
associated with risk of phenotypic subgroupings of CHDs. There were suggestions of slight 
positive and negative associations with some CHD phenotypic subtypes; however, these 
associations were imprecise and not statistically significant (p > 0.05 for all associations).
Our previous research in the NBDPS indicated that estimated maternal occupational 
exposure to PAHs was associated with gastroschisis (AOR, 1.75; 95% CI, 1.05–2.92; Lupo 
et al., 2012). In addition, there have been two studies in China reporting an association 
between PAHs and neural tube defects (Naufal et al., 2010; Ren et al., 2011). Because PAHs 
are lipophilic, they readily penetrate cellular membranes (including the placenta; Agency for 
Toxic Substances and Disease Registry, 1995). During PAH metabolism, enzymatic activity 
can result in the formation of reactive intermediates that covalently bind to DNA, forming 
adducts. DNA adducts have been shown to result in a spectrum of cellular mutations that 
may be teratogenic (Wells et al., 2010). Although exposure to PAHs in developing fish 
results in CHDs (Clark et al., 2010; Farwell et al., 2006; Incardona et al., 2004; Wassenberg 
and Di Giulio, 2004; Wassenberg et al., 2005), our results did not support this association in 
humans. If PAHs do contribute to the risk of human malformations, it is possible that their 
effects may be specific to certain organ systems; associations may be stronger for certain 
types of birth defects (e.g., gastroschisis, neural tube defects) compared to CHDs. In 
addition, timing, dose, and route may be critical in relation to disease etiology.
Our findings must be considered in the light of certain limitations. The main limitation is 
related to the occupational exposure assessment. Although our approach relied on expert 
industrial hygienist consensus, there is still a potential for misclassification when assigning 
exposure based on questionnaire responses about jobs. However, our approach is superior to 
a strategy that relies solely on maternal self-report of PAH exposure, because knowledge of 
PAH exposure is likely to be limited (Olsson et al., 2010). Although the use of personal 
monitoring or biomarkers of exposure would be preferred, these data are typically 
unavailable in population-based studies of birth defects (Yoon et al., 2001). In addition, as 
PAHs are lipophilic, exposure that occurred before the 3 months preceding conception may 
be important; however, this information is not collected as part of the NDBPS. The absence 
of information on environmental sources of PAHs is also a potential limitation, but 
occupational exposures are generally higher than those found in the environment (Brandt 
and Watson, 2003). We also evaluated and took into account potential confounding by direct 
and secondhand smoke and meat consumption, which are important sources of 
environmental PAHs (Boers et al., 2005; Hansen et al., 2008). However, given that such 
assessment was based on interview data subject to misclassification error, residual 
confounding remains a potential source of bias for possible associations.
Strengths of this study include the use of data from the NBDPS, the largest population-based 
case-control study exploring risk factors for birth defects; it has an extensive occupational 
PAH exposure assessment available for study participants from 1997 to 2002. As part of the 
NBDPS, we also had information on potentially important confounding factors such as 
maternal nutrition, pre-pregnancy BMI, and smoking. In addition, the case classification 
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undertaken by NBDPS pediatric cardiologists and clinical geneticists to exclude cases owing 
to single gene disorders or chromosomal abnormalities resulted in more homogeneous CHD 
case groups compared with studies that do not use similar criteria.
To our knowledge, this is the first study evaluating the association between maternal 
occupational exposure to PAHs and CHDs. We observed small positive associations with 
some CHD phenotypic subtypes, although effect measure estimates were generally 
imprecise. Future investigations could be improved by working with larger sample sizes in 
populations with higher potential for PAH exposure and by incorporating information on 
maternal and fetal genotypes related to PAH metabolism, because ongoing research suggests 
that genetic susceptibility in combination with environmental exposures predisposes 
individuals to the greatest risk (Whyatt et al., 1998; Wassenberg and Di Giulio, 2004; 
Wassenberg et al., 2005; Shimada, 2006; Sanyal and Li, 2007).
Acknowledgments
We thank the California Department of Public Health Maternal Child and Adolescent Health Division for providing 
data.
Supported by the American Heart Association (to P.J.L., grant no. 10BGIA3060022); cooperative agreements under 
PA 96043, PA 02081, and FOA DD09-001 from the Centers for Disease Control and Prevention (CDC) to the 
Centers for Birth Defects Research and Prevention participating in the National Birth Defects Prevention Study; 
Grant number: U01DD000494. The CDC to the Texas Department of State Health Services. Contract 
200-2000-08018 from the CDC and the National Institute for Occupational Safety and Health.
References
Agency for Toxic Substances and Disease Registry. Toxicological Profile for Polycyclic Aromatic 
Hydrocarbons (PAHs) (Update). U.S. Department of Health and Humans Services, Public Health 
Service Agency for Toxic Substances and Disease Registry; 1995. 
Boers D, Zeegers MP, Swaen GM, et al. The influence of occupational exposure to pesticides, 
polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on 
prostate cancer: a prospective cohort study. Occup Environ Med. 2005; 62:531–537. [PubMed: 
16046605] 
Botto LD, Lin AE, Riehle-Colarusso T, et al. Seeking causes: xlassifying and evaluating congenital 
heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007; 79:714–727. 
[PubMed: 17729292] 
Brandt HC, Watson WP. Monitoring human occupational and environmental exposures to polycyclic 
aromatic compounds. Ann Occup Hyg. 2003; 47:349–378. [PubMed: 12855487] 
Clark BW, Matson CW, Jung D, et al. AHR2 mediates cardiac teratogenesis of polycyclic aromatic 
hydrocarbons and PCB-126 in Atlantic killifish (Fundulus heteroclitus). Aquat Toxicol. 2010; 
99:232–240. [PubMed: 20605646] 
Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 
2008; 199:237, e231–239. [PubMed: 18674752] 
Farwell A, Nero V, Croft M, et al. Modified Japanese medaka embryo-larval bioassay for rapid 
determination of developmental abnormalities. Arch Environ Contam Toxicol. 2006; 51:600–607. 
[PubMed: 17009128] 
Gilboa SM, Correa A, Botto LD, et al. Association between prepregnancy body mass index and 
congenital heart defects. Am J Obstet Gynecol. 2010; 202:510.e51–51.e10.
Hansen AM, Mathiesen L, Pedersen M, et al. Urinary 1-hydroxypyrene (1-HP) in environmental and 
occupational studies–a review. Int J Hyg Environ Health. 2008; 211:471–503. [PubMed: 18222724] 
Harper, PS. Practical genetic counselling. 6th. New York: Hodder Arnold; 2004. 
Lupo et al. Page 8













Herdt-Losavio ML, Lin S, Chapman BR, et al. Maternal occupation and the risk of birth defects: an 
overview from the National Birth Defects Prevention Study. Occup Environ Med. 2010; 67:58–66. 
[PubMed: 20029025] 
Incardona JP, Collier TK, Scholz NL, et al. Defects in cardiac function precede morphological 
abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol Appl 
Pharmacol. 2004; 196:191–205. [PubMed: 15081266] 
Jackson LW, Correa-Villasenor A, Lees PS, et al. Parental lead exposure and total anomalous 
pulmonary venous return. Birth Defects Res A Clin Mol Teratol. 2004; 70:185–193. [PubMed: 
15108245] 
Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular 
defects: current knowledge: a scientific statement from the American Heart Association Council 
on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. 
Circulation. 2007; 115:2995–3014. [PubMed: 17519397] 
Langlois PH, Hoyt AT, Lupo PJ, et al. Maternal occupational exposure to polycyclic aromatic 
hydrocarbons and risk of neural tube defect-affected pregnancies. Birth Defects Res A Clin Mol 
Teratol. 2012 (in press). 
Lupo PJ, Langlois PH, Reefhuis J, et al. Maternal occupational exposure to polycyclic aromatic 
hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention 
Study. Environ Health Perspect. 2012; 120:910–915. [PubMed: 22330681] 
Naufal Z, Zhiwen L, Zhu L, et al. Biomarkers of exposure to combustion by-products in a human 
population in Shanxi, China. J Expo Sci Environ Epidemiol. 2010; 20:310–319. [PubMed: 
19277067] 
Olsson AC, Fevotte J, Fletcher T, et al. Occupational exposure to polycyclic aromatic hydrocarbons 
and lung cancer risk: a multicenter study in Europe. Occup Environ Med. 2010; 67:98–103. 
[PubMed: 19773276] 
Rasmussen SA, Olney RS, Holmes LB, et al. Guidelines for case classification for the National Birth 
Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2003; 67:193–201. [PubMed: 
12797461] 
Ren A, Qiu X, Jin L, et al. Association of selected persistent organic pollutants in the placenta with the 
risk of neural tube defects. Proc Nat Acad Sci U S A. 2011; 108:12770–12775.
Rocheleau CM, Lawson CC, Waters MA, et al. Inter-rater reliability of assessed prenatal maternal 
occupational exposures to solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occup 
Environ Hyg. 2011 (in press). 
Sanyal MK, Li YL. Differential metabolism of benzo[alpha]pyrene in vitro by human placental tissues 
exposed to active maternal cigarette smoke. Birth Defects Res B Dev Reprod Toxicol. 2007; 
80:49–56. [PubMed: 17294456] 
Selevan SG, Kimmel CA, Mendola P, et al. Identifying critical windows of exposure for children’s 
health. Environ Health Perspect. 2000; 108(Suppl 3):451–455. [PubMed: 10852844] 
Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of 
carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006; 21:257–276. 
[PubMed: 16946553] 
United States Department of Labor Bureau of Labor Statistics. North American Industry Classification 
System (NAICS). 1997. Available at:http://www.bls.gov/bls/naics.htm Accessed October 27, 2009
United States Department of Labor Bureau of Labor Statistics. Standard occupational classification. 
2000. Available at:http://www.bls.0gov/soc/soc_majo.htm Accessed October 27, 2009
Wassenberg DM, Di Giulio RT. Synergistic embryotoxicity of polycyclic aromatic hydrocarbon aryl 
hydrocarbon receptor agonists with cytochrome P4501A inhibitors in Fundulus heteroclitus. 
Environ Health Perspect. 2004; 112:1658–1664. [PubMed: 15579409] 
Wassenberg DM, Nerlinger AL, Battle LP, et al. Effects of the polycyclic aromatic hydrocarbon 
heterocycles, carbazole and dibenzothiophene, on in vivo and in vitro CYP1A activity and 
polycyclic aromatic hydrocarbon-derived embryonic deformities. Environ Toxicol Chem. 2005; 
24:2526–2532. [PubMed: 16268154] 
Lupo et al. Page 9













Wells PG, McCallum GP, Lam KC, et al. Oxidative DNA damage and repair in teratogenesis and 
neurodevelopmental deficits. Birth Defects Res C Embryo Today. 2010; 90:103–109. [PubMed: 
20544694] 
Whyatt RM, Bell DA, Jedrychowski W, et al. Polycyclic aromatic hydrocarbon-DNA adducts in 
human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis. 1998; 
19:1389–1392. [PubMed: 9744534] 
Willett WC, Reynolds RD, Cottrell-Hoehner S, et al. Validation of a semi-quantitative food frequency 
questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 1987; 87:43–47. [PubMed: 
3794132] 
Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public 
Health Rep. 2001; 116(Suppl 1):32–40. [PubMed: 11889273] 
Lupo et al. Page 10

























Lupo et al. Page 11
Table 1
Maternal Demographic and Behavioral Factors among Congenital Heart Defect Cases and Controls, National 
Birth Defects Prevention Study, 1997–2002a
CHD cases (n = 1907) Controls (n = 2853)
n % n %
Infant sexb
Male 1036 54.4 1422 49.9
Female 868 45.6 1429 50.1
Maternal age (years)
<20 147 7.7 235 8.2
20–34 1455 76.3 2208 77.4
≥35 305 16.0 410 14.4
Race/ethnicity
Non-Hispanic White 1246 65.4 1838 64.6
Non-Hispanic Black 256 13.4 357 12.5
Hispanic 319 16.7 513 18.0
Other 85 4.5 138 4.9
Education (years)
<12 213 11.2 290 10.2
12 521 27.4 714 25.1
13–15 550 28.9 858 30.1
≥16 620 32.5 986 34.6
Body mass index (kg/m2)b
Underweight (<18.5) 94 5.0 149 5.3
Normal weight (18.5–24.9) 995 53.3 1594 57.1
Overweight (25–29.9) 435 23.3 638 22.8
Obese (≥30) 343 18.4 413 14.8
Parity
0 845 44.4 1261 44.2
≥1 1060 55.6 1591 55.8
Gestational diabetesb
No 1754 94.0 2691 96.1
Yes 113 6.0 110 3.9
Folic acid supplement usec
No 927 48.6 1352 47.4
Yes 980 51.4 1501 52.6
Alcohol usec
No 1100 58.1 1586 55.8
Yes 792 41.9 1256 44.2
Smokingb,c
Nonsmoker 1474 77.3 2260 79.2
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CHD cases (n = 1907) Controls (n = 2853)
n % n %
Light (<15 cigarettes per day) 297 15.6 408 14.3
Moderate (15–24 cigarettes per day) 97 5.1 152 5.3
Heavy (≥25 cigarettes per day) 39 2.0 33 1.2
Secondhand smoke at homec
No 1543 81.0 2338 82.0
Yes 363 19.0 513 18.0
Secondhand smoke at workc
No 1515 79.5 2297 80.78
Yes 390 20.5 547 19.2
Meat consumption
None or less than once per month 270 14.2 391 13.7
One to three times per month 523 27.4 714 25.1
Four times per month 550 28.9 843 29.6
More than four times per month 563 29.5 899 31.6
a
Excluded nonworking mothers, associated and complex CHDs, infants with extracardiac defects (i.e., multiple defects), maternal pregestational 
diabetes, multiple gestations, and first-degree family history of CHDs.
b
Chi-square test: p < 0.05.
c
One month before pregnancy through the third month of pregnancy.
CHD, congenital heart defect.
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Table 2
Maternal Jobs Linked to Standard Occupation Code Major Job Groups (n = 23) for Mothersa of Congenital 
Heart Defect Cases and Controls by Polycyclic Aromatic Hydrocarbon Exposure Status, National Birth 
Defects Prevention Study, 1997–2002
Standard occupation code major group
Cases Controls
Exposed Unexposed Exposed Unexposed
n n n n
Management 0 180 3 286
Business and financial operations 0 76 0 132
Computer and mathematical 0 28 1 45
Architecture and engineering 0 17 1 11
Life, physical, and social science 0 15 0 34
Community and social services 0 35 1 61
Legal 0 31 0 29
Education, training, and library 0 144 1 250
Arts, design, entertainment, sports and media 1 37 0 37
Health care practitioners and technical 0 129 0 220
Health care support 3 98 2 137
Protective service 0 13 0 24
Food preparation and serving related 32 116 47 186
Building and grounds cleaning and maintenance 0 48 1 64
Personal care and service 3 66 7 118
Sales and related 25 223 28 322
Office and administrative support 1 420 0 553
Farming, fishing, and forestry 0 13 1 43
Construction and extraction 1 3 0 4
Installation, maintenance, and repair 1 3 1 4
Production 5 89 5 117
Transportation and material moving 2 37 2 52
Military specific 0 0 0 3
a
Individuals may be represented twice if multiple jobs were held during the critical window of exposure (i.e., 1 month before pregnancy through 
the third month of pregnancy). Some jobs were not linked to the standard occupation code major job groups.
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